L-778,123

DRUG2 trials

Sponsors

Memorial Sloan Kettering Cancer Center

Conditions

Head and Neck CancerLymphomaUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors

CompletedNCT00003430

Memorial Sloan Kettering Cancer CenterHead and Neck Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Start: 1998-04-30End: 2000-04-30Target: 40Updated: 2013-06-25

Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas

CompletedNCT00004057

Memorial Sloan Kettering Cancer CenterLymphoma, Unspecified Adult Solid Tumor, Protocol Specific

Start: 1998-12-31End: 2000-12-31Target: 40Updated: 2013-06-21